Mounjaro, Zepbound shortage eases
Health Secretary Wes Streeting has suggested that new weight loss injections such as Ozempic or Mounjaro could be given to ...
In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...
A new study found that obese teens prescribed with weight loss drugs are less likely to have suicidal thoughts.
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has ...
Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...
A study will assess changes in employment status and sick days when people take the drug. Weight loss drugs could be given to unemployed people with obesity as a way of getting them into work, British ...
(AP) — The medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight, or about 60 pounds on average when combined with ...